Abstract
Introduction
Dopamine produced in the renal proximal tubule from circulating L-DOPA acts as a paracrine and autocrine hormone to regulate greater than 50% of sodium excretion in animals and humans on moderately high salt intake. [1] [2] [3] Dopamine exerts its natriuretic effect by acting with cell surface receptors and intracellular pathways to stimulate intracellular adenylyl cyclase (AC) and phospholipase C (PLC) activities and inhibit sodium transport. There are 5 dopamine receptors expressed in renal proximal tubule cells (RPTCs): the D 1 -like (D 1 R and D 5 R) and the D 2 -like (D 2 R, D 3 R, D 4 R) receptors, that interact with other systems including the renin angiotensin system to regulate renal sodium excretion. 4, 5 In mice, a deficiency in local production of dopamine results in hypertension and a decrease in longevity. 6 The D 5 R is of particular interest because it has a 10-fold higher affinity for dopamine than D 1 R but has an 80% homology in the transmembrane domain and a 30% homology in the N and C termini. 7 Both D 1 R and D 5 R are linked to G αS . 7 The D 1 R, but not D 5 R, also couples to G O 8 and G Olf 9 while the D 5 R but not D 1 R, couples to G Z 10 and Gα 12/13 . 11 In the rat forebrain, D 1 -like receptors couple to both G αS and G αq while in the rat hippocampus and amygdala, D 1 -like receptors couple only to G αq. 12 In contrast, in hippocampal and brain cortical and striatal tissues of D 5 R -/-mice, PLC is not activated in the brain following stimulation with dopamine, the non-selective D 1 R/D 5 R agonist SKF38393, or the PLCselective D 1 R/D 5 R agonist SKF83959. 13, 14 This suggests that in specific areas in the brain, D 1 R couples preferentially to AC and the D 5 R couples to PLC. 15 Which D 1 -like receptor subtype is linked to Gαq and PLC in cells in which both D 1 -like receptors are expressed is not clear. While the D 1 R and D 5 R may have different anatomical distributions in the brain, 16 both the renal D 1 R and D 5 R are found in specific nephron segments (proximal convoluted and straight tubules, thick ascending limb of Henle, distal convoluted tubule and cortical collecting duct), suggesting a possible interaction between these receptors. 17 We have reported that in renal cortical membranes, D 1 -like receptors are linked to Gαq and that PLC activity can be stimulated by D 1 -like receptors independent of AC. 18 Others have reported that the linkage of renal D 1 -like receptors to PLC may be observed to a greater extent in rats fed a high salt diet. 19 We have previously shown that both D 1 R and D 5 R are expressed in RPTCs. 20 However, little is known about their physical association and the relative contribution of each receptor on AC and PLC signaling in a single cell type. Studying the D 1 R and D 5 R in a single cell type is important because similarities and differences in signaling pathways may be tissue specific (vide supra). 22 gene in mice results in elevation of blood pressure. Increased salt intake further increases the high blood pressure of D 5 R -/-mice. 23, 24 The effect of salt intake on blood pressure in D 1 R -/-mice has not been reported. Since both the D 1 R and D 5 R are important in the control of blood pressure, 3-5, 17, 24-26 in part by regulation of renal sodium transport, we further examined the AC and PLC pathways and their relationship to NHE3 and NaKATPase using agonists that have selectivity to D 5 R, AC, and PLC and silencing of D 1 R or D 5 R (see our model display of these pathways and agonists). These studies were performed using human RPTCs with normal D 1 R and AC coupling, since a fully functional D 1 R is necessary for D 1 R/D 5 R agonist-mediated inhibition of NHE3 and NaKATPase. 27 
Results
We demonstrated that the D 1 R and D 5 R were physically associated in the same macromolecular protein complex using a co-immunoprecipitation method ( Figure 1 ). We further demonstrated that the amount of D 5 R protein pulled down using the D 1 R antibody was increased following fenoldopam (FEN, 1 μmol/L, 30-min) stimulation (P<0.001, N=6, one immunoblot is shown in Figure 1 inset). Further evidence of association is seen by reciprocal co-immunoprecipitation with D 1 R and D 5 R, and adequate washing is demonstrated by inclusion of the appropriate non-specific IgG antibody controls in the initial immunoprecipitation ( Figure S1 ).
Confocal microscopy was used to determine if the two receptors co-localize in renal cortical proximal tubules. The confocal immunofluorescence images demonstrated that the D 1 R and D 5 R were both highly expressed in the proximal tubule and showed a similar sub-cellular localization, i.e., sub-apical position at the base of the microvilli ( Figure S2 ). The composite images of both human and rat tubules demonstrated extensive co-localization in the subapical region. This sub-apical localization of the two receptors was verified by co-staining with a sub-apical marker α-adaptin (data not shown).
FRET analysis of these experiments was not possible because the two antibodies that work well on fixed tissue bind to either intracellular (D 1 R) or extracellular (D 5 R) epitopes that are on opposite sides of the phospholipid bilayer and are therefore outside the distance measurable by FRET. We therefore investigated their possible heterooligomerization using live-FRET microscopy. Figure S3 A new D 5 R antagonist (LE-PM436) 28 . By contrast, the PLC-activator SKF83959 (10 μmol/L, 20-min) increased PLC activity and Ca ++ levels but not cAMP ( # P<0.001 vs VEH, N=4-17) levels. When these two agonists (SKF83822 and SKF83959) were combined there was no additive effect (data not shown).
We next utilized siRNA technology. The efficacy of the siRNA is demonstrated in Figure  S4 , using immunofluorescence staining of transfected RPTCs. RPTCs that were transfected with D 1 R or D 5 R siRNA had a marked decrease in their respective expression levels compared to scrambled (SCR) RNA control, using the same timing and format as the sodium assays (P<0.001 vs SCR, N=4). Figure 5 shows that D 1 R siRNA blocked the FENstimulated increase in cAMP accumulation and PLC activity (*P<0.05 vs SCR, N=16 for ICUE3, N=4 for CYPHR). By contrast, the D 5 R siRNA blocked only the FEN-mediated increase in PLC activity (*P<0.05 vs SCR, N=4), while the combination of the D 1 R and D 5 R siRNAs blocked both signaling pathways (*P<0.05 vs SCR, N=14 for ICUE3, N=4 for CYPHR). These data indicate that in RPTCs, the D 1 R is coupled to both AC and PLC whereas the D 5 R is linked mainly to PLC. This is in contrast to the linkage of D 5 R to AC in HEK293 cells heterologously expressing D 5 R.
We next determined how selective D 1 R and/or D 5 R stimulation or reduction with siRNA would ultimately affect sodium influx via NHE3 or sodium efflux via NaKATPase ( Figure 6 ). The D 1 R/D 5 R agonist FEN (1 μmol/L, 30-min) inhibited both NHE3-mediated sodium influx and NaKATPase-mediated sodium efflux in immortalized RPTCs (*P<0.0001 vs VEH, N=6, Figure 6 , Panel A). The addition of U73122 (10 μmol/L), LE-PM436 (1 nmol/L), or LE300 (10 μmol/L), by themselves did not affect sodium influx or efflux (data not shown) but their co-incubation with FEN returned the sodium influx and efflux to VEH levels. The D 1 -like receptor AC-specific activator SKF83822 (10 μmol/L, 20-min) inhibited both NHE3 and NaKATPase ( # P<0.001 vs VEH, N=6). By contrast, the PLC-activator SKF83959 (10 μmol/L, 20-min) did not inhibit either NHE3 or NaKATPase activity. This suggests that the primary inhibitory signaling pathway for NHE3 and NaKATPase is via AC. The combination of SKF83822 and SKF83959 inhibited both NHE3 and NaKATPase (*P<0.0001 vs VEH, N=6), and to a greater extent than SKF83822 alone. As shown in Figure 6 (Panel B), the FEN-mediated inhibition of sodium influx and efflux were reversed by siRNA specific to D 1 R, D 5 R, or both D 1 R and D 5 R (*P<0.05 vs SCR, **P<0.001 vs SCR, N=6). These data indicate that both the cAMP and PLC pathways are necessary for inhibition of sodium influx and efflux, involving both D 1 R and D 5 R.
In order to control for the effects of the antagonists alone (U73122, LE-PM436 and LE300), each one was included in both the sodium influx and efflux assays and showed no effect in either assay (data not shown). Antisense oligos to the D 1 R or D 5 R 20 recapitulated the effects we observed with the specific inhibitors of either D 1 R or D 5 R (data not shown).
Discussion
The interplay between the D 1 R and D 5 R, two closely related cell surface receptors that share the same endogenous agonist (dopamine), is important in understanding the role of dopamine in cell function. The D 1 R and D 5 R are expressed in different areas of the brain, which suggests that the D 5 R has a distinct role in neurotransmission when compared to the D 1 R. 16 However, the direct interaction of endogenously expressed D 1 R and D 5 R has not been well studied. Dopamine receptors outside the central nervous system are often expressed within the same cells. For example, the D 1 R and D 5 R are both expressed in the tunica media of systemic arteries 30 and both are expressed in almost all segments of the nephron where active sodium transport occurs. 17 D 1 R and D 5 R heterologously co-expressed in HEK293 cells have been found to hetero-oligomerize. 31 In our current studies, we demonstrated that the D 1 R and D 5 R were not only present in RPTCs, but they co-localized, co-immunoprecipitated, and directly physically interacted, as demonstrated by FRET microscopy. The co-localization of the D 1 R and D 5 R was seen in a compartment at the base of the microvilli in the proximal tubule in human and rat kidneys. Microvilli are key structures in the renal proximal tubule that serve to increase the luminal membrane surface area for protein and peptide uptake and catabolism and ion transport. Microvilli also serve as sensors for sampling and adjusting the concentration of various solutes within the glomerular filtrate in response to mechanotransduction. 32 The D 5 R and D 1 R were found clustered in a tight band in the sub-microvilliary space, where they could be rapidly recruited to the plasma membrane in response to cell surface receptor stimulation.
We demonstrated in the current report that the D 1 R/D 5 R agonist FEN caused recruitment of the D 1 R to the cell surface plasma membrane, corroborating our previous report using surface biotinylation and western blot analysis. 33 We have reported that salt-sensitive hypertension in humans correlates with defective recruitment of D 1 R to the cell surface of urinary RPTCs when their intracellular sodium levels were increased. 34 In contrast, we found that the D 5 R was not recruited to the cell surface but appears to have a constant cell membrane concentration not altered by agonist stimulation. 35 We further found that this constant level of D 5 R at the cell membrane was lower in RPTCs whose D 1 R coupling to AC was defective. 35 The D 5 Previous reports have demonstrated that D 1 -like receptor stimulation inhibited various ion transporters and exchangers in the renal proximal tubule luminal membrane (NHE3, Na + Pi co-transporter, and the Cl -/HCO 3 -exchanger) and ion exchanger and sodium pump in the basolateral membrane (NaKATPase, and the Cl -/HCO 3 -exchanger). 26 However, it is not known which D 1 -like receptor subtype, D 1 R or D 5 R, mediates these effects. In D 5 R deficient mice, distal tubular sodium transporters/channels (Na + K + 2Cl -co-transporter, Na + Cl -co-transporter, and the α and γ subunits of the epithelial sodium channel) were increased, 39 suggesting a tonic inhibition of the activity of these proteins via the D 5 R. In the current experiments, we showed that in addition to a functional D 1 R, D 5 R stimulation was also necessary for the inhibition of NHE3-mediated sodium influx and NaKATPasemediated sodium efflux following D 1 R/D 5 R receptor stimulation. Taken together with our previous studies demonstrating that the D 5 R is responsible for the tonic down-regulation of the anti-natriuretic angiotensin II type 1 receptor (AT 1 R) in rat and human RPTCs, these data suggest that the D 1 R is the mediator, while the D 5 R as part of the D 1 R/D 5 R heteromer and PLC signaling acts as the modulator, of the inhibition of sodium transport. Our proposed model for these pathways and their roles in sodium transport (NHE3 and NaKATPase) regulation is shown in Figure 7 .
Previous studies on the physiological effects of dopamine and synthetic dopamine agonists and antagonists have been confounded by the lack of a selective antagonist to either receptor. The recent availability of LE-PM436 will now enable the in vivo study of the selective roles of the renal D 1 R and D 5 R receptors. An overactive renal renin angiotensin system (RAS) and diminished function of the renal dopaminergic system has been associated with hypertension and salt-sensitivity in-vivo in mouse, rats, and humans. 40 One class of anti-hypertensive pharmaceutical drugs that affect these systems and consequently blood pressure in all three species are AT 1 R blockers. One of the many beneficial effects of AT 1 R blockers may be mediated through the pathways described in this paper. Higher expression of angiotensinogen in high salt conditions, as well as numerous SNPs in the RAS system such as ACE, angiotensinogen or AT 1 R, could lead to overactive AT 1 R stimulation, downregulation of the D 5 R and subsequent loss of D 5 R-PLC specific natriuresis. 41 Use of AT 1 R blockers under high salt conditions would allow the increased conversion of L-dopa to dopamine in the proximal tubule to stimulate both the D 1 R and D 5 R to aid in natriuresis and lower blood pressure since there would be diminished counter-regulation by the AT 1 R. The implications of this paper may also suggest reasons why AT 1 R blockers are not always effective; patients with proximal tubule D 1 R -AC uncoupling may have diminished high salt D 5 R-PLC induction of natriuresis. In animal models, the drug LE-PM436 would allow testing of these hypotheses in acute studies that otherwise would be difficult with siRNA or knockout models where gene compensation could alter the proper interpretation of the results.
Methods

RPTC Culture
RPTCs were obtained from normal tissue from nephrectomies in human subjects, under an institutional review board-approved protocol according to the Declaration of Helsinki, Title 45, Part 46, and U.S. Code of Federal Regulations. Cell lines were immortalized as previously described 33, 42, 43 and demonstrated only proximal tubule-specific characteristics as extensively detailed in our previous publication. 27 We have identified two distinct subpopulations of RPTCs, those that have a D 1 R with normal AC coupling, and those with defective D 1 R to AC coupling (uncoupled). We utilized only the normally-coupled RPTC lines i7448, i16, and i22 in the current studies, since a fully functional D 1 R is necessary in our sodium transport assays. 27
HEK293 Cell Culture and Transfection
Human embryonic kidney (HEK293) cells were obtained from ATCC (Manassas, VA) and grown in DMEM high glucose with 10% FBS. They were stably transfected with human D 1 R and D 5 R as previously described 23, 44 and these cells were used to confirm the specificity of LE-PM436 for the D 5 R. . PLC inhibitor U73122, cAMP-specific activator SKF83822, and PLC-specific activator SKF83959 were also used. Details about these and the ouabain and EIPA used in the sodium transport assays (including source information) can be found in Table S1 in the Online Supplement.
Co-Immunoprecipitation of D 1 R and D 5 R
Co-immunoprecipitation of the two receptors was performed as previously described 33 using rabbit D 1 R antibody (1:50 dilution, sc-14001, Santa Cruz Biotechology). The detection step used goat polyclonal anti-D 5 R (1:100 dilution, sc-1440 Santa Cruz Biotechology), followed by a donkey anti-goat IR Dye 800 secondary antibody (1:15,000, LI-COR Biosciences). Non-specific rabbit IgG (Sigma) was used as a negative control immunoprecipitating antibody and no D 5 R-specific signal was detected. Lack of cross reactivity with the respective antibodies was verified using the stably transfected D 1 R-HEK293 and D 5 R-HEK293 cells. The FEN effect was measured after 30-min (1 μmol/L FEN).
Immunofluorescence
The basic immunofluorescent staining procedure has been reported. 27 The D 1 R antibody used on fixed tissue was from Dr. Jose's laboratory. 45 The 3 rd extracellular loop-specific D 1 R antibody used for cell surface labeling was from Dr. Carey's laboratory. 46 
Fluorescent Biosensors for cAMP Accumulation (ICUE3) and PLC Activation (CYPHR)
cAMP accumulation and PLC activation were measured by intracellular real-time kinetic assays using the fluorescent biosensors ICUE3 and CYPHR, respectively. This involved transfecting RPTCs with a plasmid containing a novel fluorescence resonance energy transfer sensor for cAMP (ICUE3) or Addgene plasmid 14864 for PLC activation (CYPHR) according to the methods of Violin et al. 48, 49 The ICUE biosensor contains a cAMP binding domain of EPAC1, a known cAMP target in proximal tubule cells necessary for NHE3 inhibition. 50 RPTCs were electroporated according to our previously optimized protocol. 33 They were allowed to recover in culture media for 24-hr before imaging. Cells were treated with combinations of agonists and antagonists and imaged with confocal microscopy every 30 sec for 20-min. The final read was used to generate the data in Figures 4 and 5 . 
NHE3-mediated Sodium Influx Assay
Details and specificity of this assay, where we use ouabain to inhibit NaKATPase and measure sodium accumulation in RPTCs, was previously published 27 and is described in the Online Supplement. The figures were made using data collected at the 30-min time point.
NaKATPase-mediated Sodium Efflux Assay
The detailed method used to measure the rate of sodium efflux was previously published 33 and is outlined in the Online Supplement. The figures were made using data collected at the 30-min time point.
Calcium Imaging
RPTCs were labeled with fura-2 AM (Invitrogen) using identical conditions established for the SBFI labeling as stated in the NHE3-mediated sodium influx assay. The fura-2 here simply replaces the SBFI used in the influx assay. The filter set and imaging parameters are also identical for the two assays. Data for this figure was collected at the 20-min time point.
cAMP Assay cAMP accumulation was measured after 30-min of agonist stimulation (SKF38393, see Table S1 ) with IBMX (500 μmol/L) using a commercial ELISA kit (Cayman Chemical) as previously described. 33 Antagonists LE-PM436 and LE300 (see Table S1 ) were added 10-min prior to the agonist incubation.
Statistical Analysis
The data are expressed as mean ± SE. Comparisons within and among groups were made by repeated measures or factorial ANOVA, respectively, followed by Holm-Sidak or Duncan's test. Student's t-test was used for two-group comparisons. P values of <0.05 were considered significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. This model lists the D 1 R and D 5 R agonists and inhibitors and depicts our proposed pathways and heteromeric structure in relation to signaling and regulation of sodium transport in a human renal proximal tubule cell (RPTC). D 1 R signaling through adenylyl cyclase (AC) and cAMP and PKA or EPAC (exchange protein activated by cAMP) can inhibit both NHE3 and NaKATPase, while the heteromeric D 1 R/D 5 R complex signaling through PLC acts to positively modulate the D 1 R activity. In RPTCs, SKF83822, which stimulates adenylyl cyclase (AC), may be a D 1 R selective agonist while SKF83959, which stimulates phospholipase C (PLC), may be a D 5 R selective agonist and inhibited by LE-PM436, the newly described D 5 R-selective antagonist. Fenoldopam and SKF38393 stimulate both D 1 R and D 5 R while LE300 inhibits both D 1 R and D 5 R. U73122 inhibits PLC activity, ouabain inhibits NaKATPase activity and EIPA inhibits NHE3 activity.
